Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


InnovaCoat® - A Revolution in Nano-Gold Conjugation

Product Image
Product Description

InnovaCoat® GOLD products are ‘conjugation friendly’ nanoparticles with a proprietary surface coat that greatly enhances colloidal stability and permits easy covalent attachment of a variety of molecules, including antibodies, analytes and other biomolecules.

In the case of immuno-gold conjugates, the antibody can be attached irreversibly without the need for extensive trials at different values of pH and/or salt concentration, as is typical of traditional ‘passive’ binding methods.

In the case of analyte-gold conjugates, the multipoint attachment of the polymer to the gold surface ensures that the analyte is firmly anchored. By contrast, direct attachment of analytes to gold surfaces by self-assembly techniques is far less stable and unwanted desorption is a significant problem.
InnovaCoat® GOLD nanoparticles can be provided in a variety of formats (e.g. 10 OD liquid or as lyophilized nanoparticles) formulated to allow a one-step reaction with antibodies.

The kits available are designed for research use and for the development of diagnostic products, specifically for the screening of potential antibodies or small scale ‘proof of principle’ studies.  Please contact us if you require any additional information and to discuss your bulk or custom conjugation requirements.

Product InnovaCoat® - A Revolution in Nano-Gold Conjugation
Company Innova Biosciences Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Innova Biosciences Ltd
Babraham Hall, Babraham, Cambridge CB22 3AT United Kingdom

Tel: +44 (0) 1223 496 170
Fax: +44 (0) 1223 496 172
Email: info@innovabiosciences.com



Scientific News
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
Immune System Implicated in Gastroschisis
UCSF researchers show that the immune system is implicated in gastroschisis. The findings could lead to improved treatments for the belly birth defect.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!